David Rizzieri
Medical Oncology · Charlotte, NCNPI 1043346877
Payments from drug & device makers
$1,755,860in general payments, 2019–2025
Across 634 payments — averaging $2769.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$387K
- Incyte Corporation$304K
- Otsuka Pharmaceutical Co., Ltd.$240K
- Gilead$142K
- Pfizer$128K
- Stemline Therapeutics Inc.$116K
- plus $439K from 30 others
General payments by program year
19
20
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 36 | $386,953 |
| Incyte Corporation | 180 | $303,809 |
| Otsuka Pharmaceutical Co., Ltd. | 22 | $240,434 |
| Gilead(2 entities) | 69 | $142,024 |
| Pfizer | 63 | $127,566 |
| Stemline Therapeutics Inc. | 73 | $115,903 |
| Astellas Pharma Global Development | 19 | $105,788 |
| Acrotech Biopharma Inc. | 1 | $63,732 |
| Amgen | 3 | $41,856 |
| Seagen Inc. | 32 | $40,010 |
| Sanofi | 26 | $39,850 |
| Jazz Pharmaceuticals Inc. | 18 | $30,268 |
| AstraZeneca | 4 | $26,361 |
| Agios Pharmaceuticals, Inc. | 15 | $23,556 |
| Astellas Pharma US Inc | 13 | $14,357 |
| Aurobindo Pharma USA, Inc. | 7 | $14,064 |
| Daiichi Sankyo Inc. | 15 | $12,320 |
| Spectrum Pharmaceuticals Inc. | 5 | $7,761 |
| Bristol Myers Squibb | 6 | $6,703 |
| Helsinn Healthcare SA | 1 | $3,300 |
| Karyopharm Therapeutics Inc. | 2 | $2,063 |
| Kadmon Pharmaceuticals LLC | 2 | $1,635 |
| Bayer | 1 | $1,125 |
| Novartis | 3 | $1,085 |
| Acceleron Pharma, Inc. | 1 | $845 |
| Epizyme, Inc. | 1 | $675 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $600 |
| GSK | 4 | $402 |
| Genentech USA, Inc. | 3 | $310 |
| Genentech, Inc. | 1 | $150 |
| Celularity Inc. | 1 | $111 |
| Intuitive Surgical | 1 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $65 |
| Medtronic | 1 | $63 |
| AVEO Pharmaceuticals, Inc. | 1 | $26 |
| Eisai Inc. | 1 | $17 |
How this compares
$1,755,860 in reported general payments places this provider in the 85th percentile of 170 medical oncology providers in North Carolina.
Other medical oncology in Charlotte
- Antoinette TanCharlotte$14.9M
- Nilanjan GhoshCharlotte$6.3M
- Kathryn MilehamCharlotte$4.7M
- Edward KimCharlotte$1.7M
- Jimmy HwangCharlotte$1.3M
- Kimberly StricklandCharlotte$1.1M
- Obiageli OgbataCharlotte$861K
- Daniel CarrizosaCharlotte$827K
- Mohamed SalemCharlotte$658K
- Ashley SumrallCharlotte$627K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.